Rolling return data shows the Nifty’s five-year annualised return at 13.3 percent, easing to 12.6 percent over ten years and ...

The Power of compounding dividends cannot be denied. Albert Einstein referred to the idea of compounding by calling it the "8th wonder of the world" For long-term investors that invest in high-quality ...

Dr. JeFreda R. Brown is a financial consultant, Certified Financial Education Instructor, and researcher who has assisted thousands of clients over a more than two-decade career. She is the CEO of ...

The S&P 500 index has yielded a 220% return in the last 10 years. Peter Mallouk, the CEO of Creative Planning Inc., highlights this data and recalls veteran investor Charlie Munger‘s insights on the ...

Jonathan Dash is founder of Dash Investments. As CIO, he is responsible for the firm’s Investment Management and Asset Allocation decisions. In his most recent annual letter to shareholders, Warren ...

The FDA’s approval of the drug Aduhelm as a treatment for Alzheimer’s disease — despite the recommendation of its own advisory committee against approval — came as a surprise to many. But to me, that ...

Pharmacists that mass-produce their own versions of popular weight-loss drugs have been put on notice after Australia's medicines regulator warned of a crackdown. Late last year, the ABC revealed ...

Editor's Note: APYs listed in this article are up-to-date as of the time of publication. They may fluctuate (up or down) as the Fed rate changes. Select will update as changes are made public. Some ...

If your AI investment needs constant justification, it’s already in trouble. One-time productivity bumps don’t move margins. Demos don’t survive budget reviews. And “AI adoption”...Read More The post ...